Elevated Call Option Trading in Cameco (CCJ)

We have seen some elevated call option activity in Cameco Corp. (NYSE: CCJ), Canada’s crowning nuclear and metal play.  The SET-2009 CALLS have been active while the stock has not. So far we have 577,000 shares traded as of 11:15 AM EST and shares are up 0.5% at $28.25 vs. an average daily volume of most 2 meg shares and a 52-week trading range of $11.78 to $30.83. While there is not firm news, this does come on the heels of news that it has filed a shelf catalogue for an substance of up to C$1 billion of senior unsecured debentures.  Here is the SEPT-2009 CALL data:

Strike.. Volume.. Op.Int.
$30.00.. 5,000   12,979
$31.00.. 12             649
$32.00.. 270        1,917
$33.00.. 2,495    2,253

JON C. OGG
AUGUST 19, 2009

HP, La-Z-Boy Beat After the Bell - MarketNewsVideo.com

HP, La-Z-Boy Beat After the Bell
MarketNewsVideo.com
Hewlett-Packard (HPQ) shares agitated in early trading after it said New Tuesday its ordinal quarter earnings fell 19 percent, to $1.6 billion, or 67 cents per ...

Analog Devices (ADI) falls on lower profit and weaker margins - BloggingStocks

Analog Devices (ADI) water on modify profit and weaker margins
BloggingStocks
Still, shares were downbound close to 5% in after-hours trading as the chipmaker reported modify than due margins in the quarter. The company earned 22 cents ...

and more »

La-Z-Boy moves to 1Q profit on fewer charges - BusinessWeek

La-Z-Boy moves to 1Q profit on fewer charges
BusinessWeek
The news sent its shares soaring 7.7 percent in after-hours trading on Tuesday, to $7.97, up 56 cents. The stock wasn't yet active premarket Wednesday. ...

and more »

Cerus Sees Swiss Eureka (CERS)

Cerus Corporation (NASDAQ: CERS) is sight a surge after announcing that the land regulatory body titled Swissmedic has approved the ingest of platelet components aerated with Cerus’ INTERCEPT Blood System. The company noted that this support extends permissible hardware instance for platelets to heptad days with INTERCEPT treatment, compared to five days without treatment.  Be advised that the land market is a small market, but is also a key to other market.  Cerus shares at 8:48 AM EST have already traded 150,000 shares and the terminal change was up over 30% at $2.35.  Average volume is about 370,000 shares and the market cap was only $58 million as of the close yesterday.  The 52-week high here is $5,02, so this one is not off its charts. -JON OGG

American Dental Partners Announces 2.26 Million Share Offering (ADPI) - FOXBusiness

American Dental Partners Announces 2.26 Million Share Offering (ADPI)
FOXBusiness
Aug 19, 2009 (SmarTrend(R) News Watch via COMTEX) ----8/19/2009-Shares of dweller Dental Partners (NASDAQ:ADPI) fell 7% in after hours trading Tuesday ...

and more »

Lilly shelves osteoporosis drug after 5-year trial - Indianapolis Star

Lilly shelves osteoporosis drug after 5-year trial
Indianapolis Star
... a "buy" recommendation, while 10 have a "hold" and fivesome have a "sell" recommendation. Lilly's have fell most 1 percent in after-hours trading, to $32.50.

and more »

Lilly shelves osteoporosis drug after 5-year trial - Indianapolis Star

Lilly shelves osteoporosis take after 5-year trial
Indianapolis Star
... a "buy" recommendation, while 10 hit a "hold" and five hit a "sell" recommendation. Lilly's have fell about 1 percent in after-hours trading, to $32.50.

and more »

Pulte takeover of Centex creates nation's largest home builder - Fort Worth Star Telegram

Pulte takeover of Centex creates nation's largest bag builder
Fort designer Star Telegram
Pulte (ticker: PHM) closed up a penny to $12.33 Tuesday, but then lost 8 cents in after-hours trading. As for Centex (CTX), it lost four cents to finish at ...

and more »

Longtop Financial's 1Q profit jumps 38 percent - The Associated Press

Longtop Financial's 1Q profit jumps 38 percent
The Associated Press
... or about 2.7 percent, to close at $27.98. In after-hours trading, the stock backward course, losing $2.51, or nearly 9 percent, to $25.47.

and more »

HP Reports Q3 Revenue, Earnings Drop, Reaffirms Outlook For Year - ChannelWeb

HP Reports Q3 Revenue, Earnings Drop, Reaffirms Outlook For Year
ChannelWeb
However, shares fell in after-hours trading, hitting just over $43.00 per share two hours after the close. For its ordinal quarter, ended July 31, ...

and more »

Trina Solar beats projections with 2Q09 profit | Cleantech Group - Cleantech Group

Trina Solar beats projections with 2Q09 acquire | Cleantech Group
Cleantech Group
Shares of the company were slightly up in after-hours trading. Trina Solar shares winking at $26.42 before announcing the news. The net acquire resulted in ...

and more »

Elevated Put/Call Options Trading in Apple (AAPL)

We are sight some unusual call option activity in Apple Inc. (NASDAQ: AAPL) today.  Because of the sort of strike prices, it is impracticable to tell how these are every being used.  Most probable it is ahead of Friday’s expiration and is probable roll-out trades in the options moving from August to Sept while there is at least a lowercase bit of time value left in the options.

So we have seen in August some 49,754 CALL contracts in these contracts alone, and that does not include the further discover of the money and further in the money contracts.  Of the PUTS traded, we have already seen 45,651 and that likewise does not include the other in and discover of the money contracts not referenced.  In September, we have seen a amount of 18,985 of the traded CALLS not including further in and discover of the money calls.  The sum for the traded PUTS in Sept was 14,923, and that likewise does not include the other contracts not referenced.

SEPTEMBER SELECT CALLS/PUTS
CALL$    Volume    Op.Int.
$155.00    4,056    16,633
$160.00    16,577    21,450
$165.00    20,683    26,646
$170.00    7,043    26,761
$175.00    1,395    15,658
PUT$    Volume    Op.Int.
$150.00    7,686    24,089
$155.00    7,173    21,982
$160.00    23,074    20,429
$165.00    7,718    10,733

OCTOBER SELECT CALLS/PUTS
CALL$    Volume    Op.Int.
$160.00    2,576    7,512
$165.00    5,055    15,285
$170.00    3,392    9,839
$175.00    3,065    8,467
$180.00    2,308    9,661
$185.00    1,353    5,987
$190.00    1,236    2,308
PUT$    Volume    Op.Int.
$140.00    2,041    34,925
$145.00    1,177    22,052
$150.00    1,884    21,178
$155.00    1,521    5,946
$160.00    3,366    15,843
$165.00    4,934    6,373

JON C. OGG
August 18, 2009

Lilly will not seek FDA approval for arzoxifene - The Associated Press

Lilly will not seek FDA approval for arzoxifene
The Associated Press
Shares of Eli Lilly lapse 34 cents to $32.50 in after-hours trading. The stock ended the regular conference up 13 cents at $32.84.

and more »

Candela 4Q income soars, but loss for year widens - CNBC

Candela 4Q income soars, but expiration for year widens
CNBC
Shares soared in after-hours trading, rising 19 percent, or 27 cents, to $1.67, after closing the regular conference up 8 cents at $1.40. ...

Unusual Options Activity in M&T Bank (MTB)

M&T Bank Corp. (NYSE: MTB) is active with a super change illumination up the extraordinary actions screen as a 10,000 contract bearish October $45/$40 place spread trades.  This is celebrity considering shares are at $58.11, as the trade, which is definitely of institutional size, is anticipating shares of the Northeast bank to fall around 30% in coming months.  MTB Q2 profit fell 75% and it is possibly a bank that will need to go to the mart to improve capital, as it is considered a regional bank with a capital shortfall.  Shares are nearing the $60 field resistance level from April highs, and prior support levels.  However, upon further analyse there also was a block of more than 75,000 shares bought at the aforementioned time, so this appears to be a hedge using a spread instead of the traditional straight place purchase.

JOE KUNKLE, OptionsHawk.com

Amgen's Vectibix Meets Goal In Colon Cancer Study - Visit Bulgaria

Visit Bulgaria
Amgen's Vectibix Meets Goal In Colon Cancer Study
Visit Bulgaria
... from the studies will be presented at an upcoming scrutiny conference in Europe, causing Amgen shares to uprise 5-cents to $59.89 in after-hours trading.

and more »

Amgen's Vectibix Meets Goal In Colon Cancer Study - Visit Bulgaria

Visit Bulgaria
Amgen's Vectibix Meets Goal In Colon person Study
Visit Bulgaria
... from the studies module be presented at an upcoming medical conference in Europe, feat Amgen shares to rise 5-cents to $59.89 in after-hours trading.

and more »

Price/Volume Alert in Novavax on Swine Flu Vaccine Data (NVAX)

Novavax Inc. (NASDAQ: NVAX) is soaring on news that its experimental H1N1 swine flu vaccine was trenchant in animal tests.  The vaccine won’t be approved nor ready for advertizement ingest in humans for two years.  At 8:53 AM EST we have already seen over 650,000 shares trade hands and th last print has the stock up 10.5% at $4.96. The 52-week high is $5.59 and cipher intensity is now over 6 million shares now that swine flu is such a buzz-word for traders. -JON OGG

Barchart US Morning Call - Inside Futures

Barchart US Morning Call
Inside Futures
Agilent Technologies (A) rose nearly 3% in after-hours trading after the biggest concern of scientific-testing equipment reported Q3 business profit of 15 cents ...

and more »